Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWNifuratel is a nitrofuran antibiotic and an antiparasitic.1,2 It is active against G. vaginalis and A. vaginae (MIC90s = 0.25 and <0.125 µg/ml, respectively).1 In vivo, nifuratel (50 mg/kg) reduces parasitic load in a mouse model of L. donovani-induced visceral leishmaniasis and a mouse model of L. major-induced cutaneous leishmaniasis.2 Formulations containing nifuratel have been used in the treatment of vulvovaginal infections and urinary tract infections.
WARNING This product is not for human or veterinary use.
1. In vitro activity of nifuratel on vaginal bacteria: Could it be a good candidate for the treatment of bacterial vaginosis? Antimicrob. Agents Chemother. 55(5), 2490-2492 (2011).
2. Ex vivo phenotypic screening of two small repurposing drug collections identifies nifuratel as a potential new treatment against visceral and cutaneous leishmaniasis. ACS Infect. Dis. 7(8), 2390-2401 (2021).